April 23, 2021
Guidance for Transgender collections under direct supervision
By NDASA
How can we help?
Search this site
Stay in touch
Give to NDASA
Invest in safe and drug-free communities and workplaces and support NDASA.
Latest News & Updates
- Jun 08, 2022Where Are We and Where Are We Going? The State of Drug Testing and the Future
- Jun 07, 2022NDASA Responds to SAMHSA Proposed Rules for Oral Fluid Testing in Federal Workplaces
- Jun 07, 2022The Great Retention: How to Hold onto Your Most Valuable Asset, Your Employees
- Jun 07, 2022First-Time Conference Attendee Vows to Return
- Jun 02, 2022Conference 2022: Three Days Packed With Teaching, Learning, Business Building and Progress
Topics We Track
- Advocacy (3)
- Business Development (1)
- Committee Reports (1)
- DOT (5)
- Drug & Alcohol Testing (19)
- Drug Legislation (8)
- Feature (50)
- FMCSA (3)
- For Drug Testing Industry Professionals (14)
- For Employers and Workplace Safety & Wellness Professionals (12)
- Industry News (10)
- Marijuana & CBD (13)
- Member Benefits (1)
- Membership (3)
- NDASA Conference (10)
- NDASA Guidance (4)
- Opioids (2)
- Resources (21)
- Substance Use (1)
- Substance Use/Addiction (3)
- Training (1)
- Uncategorized (7)
- Workplace Safety (4)